acute lymphoblastic leukemia

This approval underscores Shire's commitment to patients with acute lymphoblastic leukaemia through continued research and evolution of asparaginase therapy," said Howard B.

Hypotriploid chromosome number in patients with B-cell Acute Lymphoblastic Leukaemia is a unique finding which, according to WHO classification of ALL, is an important prognostic factor itself and these cases have a favourable prognosis.

Last night, the family of Ben Charlton, who was diagnosed with acute lymphoblastic leukaemia two years ago, welcomed the new drug trial.

Risk factors for intellectual and educational sequelae of cranial irradiation in childhood acute lymphoblastic leukaemia.

Conclusion: Relapse in acute lymphoblastic leukaemia was common, although treatment modalities are improving day by day.

The company plans to start Phase I clinical trials in both B-cell non-Hodgkin Lymphoma and B-cell Acute Lymphoblastic Leukaemia.

Again he will be joined by a local hero, football-mad Lucas Sutheren, 12, who was diagnosed with acute lymphoblastic leukaemia in January last year.

Clinical significance of minimal residual disease at day 15 and at the end of therapy in childhood acute lymphoblastic leukaemia.

Keywords: Acute lymphoblastic leukaemia, Survival, Developing country, Prognostic factors.

Acute tumour lysis syndrome following a single-dose corticosteroid in children with acute lymphoblastic leukaemia.

Clofarabine has recently been approved by the FDA for the treatment of relapsed/refractory acute lymphoblastic leukaemia in pediatric patients.

CCIA Group Leader Dr Maria Kavallaris, said her research is currently focused on drug resistance in acute lymphoblastic leukaemia, the most common type of cancer in children up to 14 years of age.

MADRID, Spain -- PharmaMar announced today that Aplidin(R)(a), its second marine-derived compound in clinical development, has been granted orphan drug status by the US Food and Drug Administration (FDA) for the treatment of acute lymphoblastic leukaemia (ALL).

for the treatment of adult and pediatric acute lymphoblastic leukaemia and acute myeloid leukaemia.